Finally, some movement on the volumes front with yesterday's volume being 293K compared with three month average of 171K (a rise of more than 70%). Importantly, the volumes led to rise in price. Or the rise was accompanied with a volume surge. Which ever way you look at it, the consolidation is perhaps over and maybe it is a breakout that was being expected. Such an event, especially when it is on Friday, is always welcome and indicates some amount of technical strength. However, we need to wait for more signals like a close above $0.85, to be sure that the uptrend is firmly in place. In fact, this level ($0.85) is the first major resistance now. Three closes, plus a weekly close above this would indicate that the stock is ready to touch recent highs of $1.25. That is presently a little far fetched now because continuous support of volumes will be required over the next few days. There is also a possibility of a little retracement after touching the $0.85 level. In any case, going below the 200 DMA is a little unlikely now. This especially true because of the expected events like earnings release and management guidance. Next few weeks will be interesting. One should be always be watchful of what happens on the fundamental front. Details on the recent deal of selling BluScience to Nutri Sci will provide a clearer estimate of the impact on future cash flows. If the impact is hugely positive, then the balance sheet will strengthen and, consequently, the stock price will also follow to catch up. Recently, some insiders may have bought chunks and this could be a sign of the fortunes of the stock in the near term. The long-term story of the company will obviously be based on the success of its drugs but short term signals are better.